Except as provided in Rule
64E-5.657, F.A.C., the licensee
shall require the authorized nuclear pharmacist to:
(1) Be certified by a specialty board whose
certification process has been recognized by the NRC or an agreement state and
who meets the requirements in paragraph
64E-5.659(2)(b),
F.A.C., of this section. (The names of board certifications which have been
recognized by the NRC or an agreement state will be posted on the NRC's Web
page at
http://www.nrc.gov/materials/miau/med-use-toolkit/spec-board-cert.html.)
To have its certification process recognized, a specialty board shall require
all candidates for certification to:
(a) Have
graduated from a pharmacy program accredited by the American Council on
Pharmaceutical Education (ACPE) or have passed the Foreign Pharmacy Graduate
Examination Committee (FPGEC) examination;
(b) Hold a current, active license to
practice pharmacy;
(c) Provide
evidence of having acquired at least 4000 hours of training/experience in
nuclear pharmacy practice. Academic training may be substituted for no more
than 2000 hours of the required training and experience; and
(d) Pass an examination in nuclear pharmacy
administered by diplomats of the specialty board, that assess knowledge and
competency in procurement, compounding, quality assurance, dispensing,
distribution, health and safety, radiation safety, provision of information and
consultation, monitoring patient outcomes, research and development;
or
(2)
(a) Have completed 700 hours in a structured
educational program consisting of both:
1. 200
hours of classroom and laboratory training in the following areas:
a. Radiation physics and
instrumentation;
b. Radiation
protection;
c. Mathematics
pertaining to the use and measurement of radioactivity;
d. Chemistry of radioactive material for
medical use; and
e. Radiation
biology; and
2.
Supervised practical experience in a nuclear pharmacy involving:
a. Shipping, receiving, and performing
related radiation surveys;
b. Using
and performing checks for proper operation of instruments used to determine the
activity of dosages, survey meters, and, if appropriate, instruments used to
measure alpha or beta-emitting radionuclides;
c. Calculating, assaying, and safely
preparing dosages for patients or human research subjects;
d. Using administrative controls to avoid
medical events in the administration of radioactive material; and
e. Using procedures to prevent or minimize
radioactive contamination and using proper decontamination procedures;
and
(b) Have
obtained written attestation, signed by a preceptor authorized user or a
residency program director who represents a consensus of residency program
faculties (as long as at least one member of the residency program faculty is
an authorized individual in the same category designated by the applicant
seeking authorized status) who meets the requirements in paragraphs
64E-5.659(1)(a),
64E-5.659(1)(b)
and
64E-5.659(1)(c)
or
64E-5.659(2)(a),
F.A.C., of this section and have demonstrated the ability to function
independently as an authorized nuclear pharmacist to fulfill the radiation
safety related duties for a medical use
licensee
.